Introduction
Excitatory neurotransmitters such as glutamate and aspartate are involved in the generation and expression of epileptic seizures in mammalian brain [1] . After its interaction with the N-methyl-D-aspartate (NMDA)-subtype of glutamate receptor, glutamate induces Ca 2+ influx that increases the neuronal nitric oxide synthase (nNOS) activity and nitric oxide (NO) production. NO plays a crucial role in learning and long-term potentiation but it may be toxic when produced in excess [2] . Depending on the stimulatory agent involved, and the concentration of NO, it may act as an anticonvulsant or a proconvulsant [3] . In any case, the reduction of NO levels has an anticonvulsant effect, suggesting a constitutive excitatory action of NO [4] . An excess of NO can react with superoxide anion leading to the formation of peroxynitrite that oxidizes sulfhydryl groups and generates the highly toxic hydroxyl radical [5] . On the other hand, inhibitory neurotransmitters such as gammaaminobutyric acid (GABA) and glycine counteract neuronal excitation. GABA, acting through GABA A subtype receptors, increases Cl ) influx leading to a hyperpolarization of cell membrane, and the antagonism of epileptic seizures [6] .
Melatonin has important regulatory effects on the central nervous system (CNS), modulating the electrical activity of the neurons [7] [8] [9] . These inhibitory actions may support the anticonvulsant [10] [11] , sedative [12] and hypnotic properties of melatonin reported in mammals [13] . In rats, melatonin inhibits the glutamate-mediated response of the striatum to motor cortex stimulation [14] [15] [16] , depresses brain excitability [8] , and prevents seizures [17] , whereas in mice, melatonin elevates the electroconvulsive threshold [18] . It was recently shown that melatonin inhibits nNOS [19] reducing NO production and neuronal excitation [20] . Melatonin also enhances GABAergic neurotransmission, modulating the GABA A -benzodiazepine receptor complex [8, 21, 22] . The GABAergic effect of melatonin possibly depends on the combined effect on membrane ion permeability with the increasing Cl ) influx to GABA Adependent chloride channel [7, 23] .
These data, in addition to the increase of endogenous melatonin production in untreated patients with active epilepsy [24, 25] , were the basis for the use of melatonin in the treatment of human epilepsy [26] . The inhibition of excitatory neurotransmission with the stimulation of the inhibitory neurotransmission may be involved in the Abstract: We examined the effect of melatonin on brain levels of amino acids and nitric oxide (NO) after pentylenetetrazole (PTZ)-induced seizures in rats. Animals were treated with melatonin (10-160 mg/kg, i.p.) 30 min before PTZ administration (100 mg/kg, s.c.), and were killed 3 hr later. At the dose of 80 mg/kg, melatonin significantly increased the latency (5.7-12.7 min) and decreased the duration (31.2-18.4 s) of the first seizure, reducing PTZ induced mortality from 87.5 to 25%. After kill, brains were removed and neurotransmitters and nitrite levels measured in prefrontal cortex (PF), parieto-temporal cortex (PF), striatum (ST), hippocampus (HP) and brain stem (BS) by high performance liquid chromatography. PTZ treatment increased glutamine levels in all brain areas studied, without changes in glutamate, gamma-amino butyric acid (GABA) and glycine. Aspartate and taurine increased in PF and PT and in HS and PT, respectively. Melatonin administration displayed a dose-dependent effect. At doses of 10-40 mg/kg, melatonin counteracted the PTZ-induced glutamine increase and reduced both glutamate and asparatate levels in the studied areas, with minor changes in GABA and glycine content. At doses of 80 and 160 mg/kg, the levels of glutamine, and glutamate, and to a lesser extent aspartate increased, whereas serine levels did not change. These two doses of melatonin also increased taurine, GABA and glycine in most brain areas studied. Treatment with melatonin (40-160 mg/kg) significantly decreased nitrite content in PT cortex, ST and BS areas of epileptic rats, without changes in the other brain regions. The results suggest that the anticonvulsant property of melatonin involves a modulation of both brain amino acids and NO production.
anticonvulsant action of melatonin. However, the role of each of these components in the antiepileptic effect of the indoleamine remains unknown. Pentylenetetrazole (PTZ), a selective blocker of the chloride channel coupled to the GABA A receptor [1] , has convulsant effects after its acute administration. In experimental animals, melatonin pretreatment attenuates the proconvulsant effect of PTZ [9] . Thus, in the present study, the effect of melatonin treatment on brain levels of amino acids and NO in PTZ-induced seizures in rats has been investigated.
Materials and methods

Animals and treatments
Adult male Wistar rats weighing 220-250 g were kept in the University's animal facility on a 12 : 12 hr light-dark cycle (light on 8 : 00 hr) and 22 ± 2°C with food and water ad libitum.
The animals were distributed in four groups: (a) control group, consisting of eight rats treated with vehicle (1 mL/ kg); (b) PTZ group, consisting of eight rats treated with PTZ (100 mg/kg in 1 mL saline, s.c.); (c) melatonin group, consisting of 8 + 8 rats treated with melatonin (40 or 160 mg/kg in 1 mL of a 2.5% ethanol:saline solution, i.p.), and (d) PTZ + melatonin groups, consisting of animals (eight animals per group) treated with 10, 20, 40, 80 or 160 mg/kg of melatonin followed by one injection of PTZ 30 min later. Due to the high mortality of animals (see Table 1 ), PTZ group and groups treated with PTZ plus melatonin at doses of 10, 20 and 40 mg/kg, were repeated at least three times to obtain a significant number of animals for statistical purposes. All experiments were performed between 09:00 and 12:00 hr. To make a solubilization of the high doses of melatonin, the indoleamine was initially dissolved in ethanol and then saline was slowly added to the ethanol solution until the adequate mixture (2.5% ethanol:saline, v/v) was reached. The procedure was performed under constant shaking. The experimental protocol was approved by the Granada's University Local Animal Care and Use Committee. All experiments were carried out according to the Spanish Government Guide and the European Community Guide for animal care.
Soon after treatment, rats were individually placed in plastic cages to observe the latency, duration and intensity of the first seizure and the percentage of surviving animals 3 hr after the treatment. The intensity of the first seizure was scored using the following five-point scale [27] : (a) stage 1, facial myoclonus and vibrissae twitching; (b) stage 2, unilateral, asymmetric or incomplete clonic or tonic seizures; (c) stage 3, rearing, often accompanied by bilateral symmetric clonic or tonic seizures; (d) stage 4, seizures beginning with the loss of righting reflex followed by a long tonus, but without a pronounced clonic component, and (e) stage 5, complete tonic-clonic seizures (both components present). During the recording of the behavioral parameters, the observer did not know the dose (or vehicle) of the drug administered to the animal being tested. Three hours after PTZ or vehicle administration, the surviving animals were killed by cervical dislocation, their brains rapidly removed and the prefrontal cortex (PF), the parieto-temporal cortex (PT), the striatum (ST), the hippocampus (HP) and the brain stem (BS) dissected following the Paxinos and Watson atlas. The tissues were weighed, placed in 2 mL HCl 0.1 N and homogenized in a Polytron. Then, 2 mL of the mixture 200:1 (v/v) chloroform:chlorhydric acid was added and vortexed, the homogenates rapidly centrifuged at 3,000 g for 30 min and the supernatants stored at )80°C until analysis. All procedures were carried out at 4°C.
Amino acid determinations
The levels of glutamate, glutamine, aspartate, serine, taurine, GABA and glycine in the dissected brain areas were analyzed by a high-performance liquid chromatography (HPLC)-fluorimetric system (Waters 715, Waters Corp., Milford, MA, USA) with the o-phthalaldehyde precolumn derivatization method [28] . Stock solutions (0.5 mm) of each amino acid standard were prepared in water, except for aspartate and glutamate, prepared in 0.5 N 14% NaHO:water. Briefly, 10 lL of 0.1 mm homoserine (internal standard) were added to 90 lL of the diluted samples (1:10). Then, 20 lL of this solution was mixed and derivatized with 10 lL of the derivatization reagent, and 1 min later 5 lL of a 5% acetic acid was added. The sample was injected in the HPLC system containing a precolumn (Waters guard-Pack C18, Waters Corp.) and a reversephase column (Waters Resolve C18 Waters Corp., 3.9 · 150 mm, particle size 5 lm). The derivatization reagent was prepared by mixing 400 lL of a methanol solution 
NO determination
Tissues obtained from the same brain areas were homogenized in cold water (0.1 g/mL). The homogenates were centrifuged at 10,000 g for 10 min at 4°C. Aliquots of the supernatants were either stored at )20°C for protein determination [29] or used to measure nitrite concentration with the Griess reagent [30] , a reliable index of NO levels. Briefly, 100 lL of each sample was incubated with 100 lL of the Griess reagent [0.1% N-(1-naphthyl) ethylenediamine dihydrochloride; 1% sulfanilamide in 5% phosphoric acid; 1:1] at room temperature for 20 min. Then, the absorbance at 550 nm was measured in an EL 800 microplate reader (Bio-Tek Inst., 1
Winooski, VT, USA). The nitrite concentration was calculated by comparison with a standard solution of known sodium nitrite concentrations, and expressed in nmol nitrite/mg protein.
Statistical analysis
Data are expressed as the mean ± S.E.M. One-way analysis of variance, followed by Tukey-Kramer multiple comparison tests were performed. For the analysis of survival the Fisher test was used. A P value <0.05 was considered statistically significant.
Results
PTZ administration induced seizures in all animals, and only one animal (12.5%) lived 3 hr after the treatment. Pretreatment with melatonin increased the number of surviving animals to seven (87.5%) ( Table 1) . Melatonin also increased the latency of the first seizure (P < 0.01) and decreased the duration of the first convulsion (P < 0.05) in a dose-dependent manner. The intensity of the first seizure also decreased after melatonin treatment (P < 0.01). In most of the cases, the effects of melatonin were significant at doses of 80 and 160 mg/kg. Fig. 1 shows the levels of excitatory (left column) and inhibitory (right column) amino acids in the different brain areas studied. PTZ administration significantly increased (P < 0.01) glutamine levels in all brain areas studied, without changes in glutamate, GABA and glycine. Aspartate and taurine increased in PF and PT and in PF and HP areas, respectively.
Melatonin administration generally counteracted the effects of PTZ (Fig. 1) . Between 10 and 40 mg/kg, melatonin counteracted PTZ-induced glutamine increase and reduced both glutamate and aspartate levels in the studied areas, with minor changes in GABA and glycine. At higher doses of melatonin (80 and 160 mg/kg), the levels of glutamine, and glutamate, and to a lesser extent the levels of aspartate, tend to increase, whereas serine levels did not change. These high doses of melatonin also increase taurine, GABA and glycine levels in most of the brain areas studied. It seems that the effects of melatonin on GABA, taurine and glycine are biphasic: at low doses, melatonin reduces the levels of these compounds, whereas higher doses of the indoleamine increase their levels. When melatonin was administered to animals without PTZ treatment (melatonin group), the levels of amino acids did not change significantly from controls (data not shown).
PTZ treatment also increased significantly (P < 0.01) NO levels in all brain regions studied (Fig. 2) . Melatonin administration partially counteracted PTZ effects and, at doses of 80 and 160 mg/kg, the indoleamine decreased NO levels in PT, ST and BS areas, without changes in the other brain regions. The most prominent effect was found in the BS, where 20 mg/kg of melatonin was enough to counteract the effect of PTZ on nitrite levels, partially. Melatonin alone did not modify the levels of NO in control rats significantly (data not shown).
Discussion
The results show that melatonin has significant behavioral effects on PTZ-induced seizures associated with a significant reduction in mortality. At the dose used in this study, PTZ produces generalized seizures (International League Against Epilepsy, ILAE, 1981) and death in most of the animals. Melatonin administration decreases the intensity and duration and increases the latency of the first crisis, reducing the lethality of the PTZ. The beneficial effects of melatonin were found at doses producing an increase in inhibitory amino acids and a reduction in nitrite levels. At these doses, melatonin also induced a slight increase in excitatory amino acids. However, low doses of melatonin that reduce excitatory amino acids, were unable to counteract the effects of PTZ. Thus, increasing inhibitory neurotransmission and/or reducing NO levels are associated with the anticonvulsant role of melatonin in this model of epilepsy. The data confirm and support previous studies in other models of epilepsy in vivo such as the amygdala kindling models in rat [31] and mouse [9] , and in human temporal slices in vitro [32] .
The dose of PTZ used in this work (100 mg/kg) was chosen from preliminary experiments in our laboratory and from the literature. Low doses of PTZ (10-40 mg/kg) are used to produce short crisis and Ôchemical kindlingÕ when they are repeatedly injected to rats [33] . To produce generalized convulsions, it is necessary to inject an acute dose of PTZ above 70 mg/kg. A 100 mg PTZ kg was injected because the objective was to produce generalized seizures with a convulsive component similar to human convulsive generalized seizures (according to the classification of the International League Against Epilepsy). A 3-hr wait was observed after PTZ and/or melatonin treatments because previously it was found that brain neurotransmitter systems are significantly modified 3 hr after melatonin administration [7, 21, 22] . Fig. 1 . Dose-dependent effects of melatonin administration on the levels of brain amino acids in pentylenetetrazole (PTZ)-treated rats. Left column: glutamate (Glu), aspartate (Asp), glutamine (Gln) and serine (Ser). Right column: taurine (Tau), glycine (Gly) and GABA. PF, prefrontal cortex; PT, parieto-temporal cortex; ST, striatum; HP, hippocampus, and BS, brain stem. Animals were injected with 100 mg/kg PTZ alone or in combination with melatonin (10 to 160 mg/kg) 30 min before administration of PTZ. Animals were killed 3 hr after PTZ injection. Data are the mean ± S.E.M of 6-8 animals per group assayed in duplicate. *P < 0.01 versus control (C); # P < 0.01 versus PTZ.
The existence of a relationship between melatonin and seizures was reported in the literature. Reiter et al. [34] reported that acute pinealectomy (which reduces plasma melatonin levels) in previously parathyroidectomized rats induces seizures and approximately 50% of them die within 48 hr of the operation. The possible causes of seizures in this model of epilepsy include changes in brain neurotransmitters such as GABA, as benzodiazepine treatment ameliorated seizures, and norepinephrine (NE). Pinealectomy increases brain excitability, decreasing the threshold for neuronal activation, and melatonin decreases neuronal excitability increasing GABA and decreasing glutamate neurotransmission [8, 14, 15] . Melatonin treatment suppresses epileptiform seizures in both adult human beings and children [11, 26] . There are several coincidences between these data and the results obtained with the model of PTZ-induced seizures. These similarities include the presence of generalized and severe sizures, the high lethality, the alteration in brain neurotransmitters, and the relation of melatonin (or the lack of it) with the disease.
BS may be a primary site of PTZ-induced epileptogenesis [1] . Neurochemical evidence suggests that PTZ binds to the picrotoxin site of the GABA receptor complex, blocking GABA-mediated inhibition [33] and thus, drugs antagonizing PTZ-induced convulsions may affect GABAergic systems. However, no changes in GABA were found after PTZ, and thus this may not be the main proconvulsant effect of the drug. Anyway, compounds that potentiate or increase GABA activity are anticonvulsant. Melatonin regulates the GABA-benzodiazapine receptor complex in rat brain, and increases GABA levels [8, [21] [22] [23] . This data show that GABA, taurine and glycine increased after melatonin treatment at doses from 40 to 160 mg/kg. Low doses of melatonin decrease glutamate and increase GABA levels, which may depend on the increase of glutamic acid decarboxylase activity [35] . These effects explain, at least in part, the anticonvulsant activity of the indoleamine [8, 11, 18] . However, high doses of melatonin partially decrease GABA and increase glutamate levels. This paradoxical effect may be related to the proconvulsant effect of the indoleamine found when high doses of melatonin were administered to an epileptic child [26] . Changes in the inhibitory amino acid taurine [36] may be related to changes in GABA levels, as GABAergic agents modify taurine release.
Although some studies have shown an increase in excitatory amino acids during epileptic seizures in humans [37] , animal experimentation has provided conflicting results. Some data suggest that seizures may be correlated with an increase in the extracellular concentration of excitatory amino acids, but other experiments show a decrease in glutamate and aspartate during epileptic seizures [38] . During PTZ-induced seizures, an imbalance between excitatory and inhibitory neurotransmitters is apparent early in the epileptogenic process [33] . Our data confirm that PTZ administration was followed by a significant increase in glutamine in the brain areas studied. Glutamate is metabolized to glutamine in the glial cells, and transported to the synaptic terminal for the subsequent resynthesis of glutamate [38] . This observation may explain the high levels of glutamine instead of glutamate found after PTZ injection. In prefrontal cortex and brain stem, serine levels increased after PTZ, which agrees with an ictal elevation of serine in epilepsy recently reported [39] . The biological significance of this finding is not clear. Serine is interconvertible with glycine that has inhibitory effects acting on the glycine receptor and excitatory effects via the glycine modulatory site on the NMDA receptor. However, the conversion of serine to glycine is not suggested by our results.
Nitric oxide, a short-lived radical synthesized from l-arginine by activation of the nNOS, has been implicated in the pathology of epilepsy [40, 41] . It was found that the inhibition of NOS decreased the anticonvulsant effects of stress against PTZ-induced convulsions [42] . Three different forms of NOS have been identified including one inducible (iNOS) and two constitutively (endothelial or eNOS and nNOS) expressed forms [43] . Increasing evidence suggests that both nNOS and iNOS participate in several important brain processes [44] . Although expression of nNOS is more evident in the cerebral cortex of epileptic patients, PTZ may induce seizures increasing nNOS-and/or iNOS-depending NO production [4, 9, 45] . However, inhibition of iNOS with aminoguanidine, an irreversible specific inhibitor of iNOS, has discarded the involvement of iNOS in PTZ-induced seizures [42] . This agrees with the suggestion that following acute stress, NO is mainly produced through constitutive NOS, while iNOS may play an important role during chronic stress. As we studied the animals after acute PTZ exposure, changes in brain NO levels parallel changes in nNOS activity. In fact, administration of nNOS inhibitors reduces the proconvulsant effects of PTZ [42] , suggesting that NO produced by nNOS plays a role in the development of PTZ-induced seizures. Similarly, antiepileptic drugs such as carbamazepin, phenobarbital and lamotrigine decrease the seizure intensity and NO generation caused by PTZ partly. Our results also show a significant increase in NO after PTZ administration in all brain areas studied. In PT, ST and BS, melatonin administration partially counteracted the PTZ-induced NO production. This effect of melatonin may depend partly on the inhibition of nNOS activity and expression [20, 46] , which in turn, decreases brain excitability [14] [15] [16] . Moreover, NO is a free radical and can react with the superoxide anion to produce peroxynitrite radical [47] . The toxicity associated with NO generation can be prevented by scavenging the superoxide [48] and by melatonin [49] that reduces NO-induced apoptosis [50] . As melatonin scavenges both NO and peroxynitrite [51] [52] [53] and protects the brain against oxidative damage [8, 54] , the antioxidant activity of the indoleamine may be involved in its anticonvulsant effect described here.
Taken together, melatonin administration results in a significant reduction in the number, intensity and amplitude of the seizures induced by acute PTZ treatment. Consequently, the typical symptoms of convulsions disappear and the percentage of survival increases dramatically. Counteracting NO-dependent excitability and oxidative damage and perhaps increasing inhibitory neurotransmission, melatonin behaves as an efficient anticonvulsant against PTZ-induced seizures. These effects should be kept in mind for the possible therapeutic use of melatonin and melatonin agonists in epilepsy [55] .
